ENCePP is the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance coordinated by the European Medicines Agency (EMA) aimed to strengthen the monitoring of the benefit-risk balance of medicinal products in Europe. The ENCePP Network represents a contact point for researchers from industry, academia and regulatory authorities interested in collaborations in the conduct of post-authorisation studies (PAS). Moreover, the Network is working to bring together expertise and resources in pharmacoepidemiology and pharmacovigilance across Europe, also with the aim to promote the development and maintaining of methodological standards and governance principles for research in this field.
Currently, the Network consists of 168 public institutions and research organisations from 18 countries.
Teddy Network is a registered network at the ENCePP since September 2015.
The next plenary meeting of the Network will take place on Tuesday, 21st November 2017, at the European Medicines Agency’s premises in London.
A first draft of the plenary meeting Agenda includes the following topics:
- ENCePP Anniversary 2007-2017
- Report from Steering Group
- Framework of collaboration between EMA and Academia
- Common data models
- ENCePP Code of Conduct – Revision 4
- EMA Patient registries initiative
Pre-registration are available at this link: https://docs.google.com/forms/d/e/1FAIpQLScVm1SzVvuIz9grfwja2rTZqDO8c92D1I2fB7UMWECVoOrdKg/viewform?c=0&w=1.